Clindamycin and metronidazole as independent risk factors for nosocomial acquisition of multidrug-resistant Pseudomonas aeruginosa.
Cipriano Souza
R
R
Vicente
A C
AC
Vieira
V V
VV
Marques
S G
SG
Soares
M das Graças A
Md
Moura
M C L
MC
Koifman
R J
RJ
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002981:Clindamycin / Q000627:therapeutic use*; D003428:Cross Infection / Q000382:microbiology*; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use*; D011552:Pseudomonas Infections / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification*
D000900:Anti-Bacterial Agents; D008795:Metronidazole; D002981:Clindamycin